New antibody combo takes on Hard-to-Treat myeloma
Disease control
ENROLLING_BY_INVITATION
This study tests a new antibody drug called HuL001, given together with two standard myeloma drugs (lenalidomide and dexamethasone), in 21 adults whose multiple myeloma has returned or stopped responding to prior treatments. The goal is to see if the combination is safe and can s…
Phase: PHASE1, PHASE2 • Sponsor: HuniLife Biotechnology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC